Anaphylaxis EMS Infectious Diseases 
RebelEM
AUGUST 3, 2023
Patients with a history of anaphylaxis with any drug were excluded from this trial Open-label study (i.e. appeared first on REBEL EM - Emergency Medicine Blog. randomization) as per protocol (i.e. randomization) as per protocol (i.e. This limits generalizability to patients with a score of 2.
RebelEM
MAY 15, 2024
Read More: Infectious Disease Society of America 2010 Clinical Practice Guidelines Life in the Fast Lane: Febrile Neutropaenia Uptodate: overview of neutropenic fever syndromes EMRAP: Risk stratification of neutropenic fever MDCalc: MASCC Score MDCalc: CISNE Score References: Ahn S, Rice TW, Yeung SJ, Cooksley T. doi: 10.1111/j.1365-2141.2011.08693.x.
Expert insights. Personalized for you.
52 
Let's personalize your content